Company Filing History:
Years Active: 1998-2006
Title: Innovations of Peter C Maisonpierre
Introduction
Peter C Maisonpierre is a notable inventor based in Croton, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions related to the TIE-2 receptor. With a total of 6 patents, his work has the potential to impact various medical applications.
Latest Patents
Maisonpierre's latest patents include innovative methods and compositions involving TIE-2 ligands. One of his key inventions provides an isolated nucleic acid molecule encoding a human TIE-2 ligand. This invention also encompasses a receptor body that specifically binds to the human TIE-2 ligand, as well as an antibody that targets this ligand. Furthermore, he has developed an antagonist of human TIE-2 and therapeutic compositions aimed at blocking blood vessel growth. His methods also promote neovascularization and the growth or differentiation of cells expressing the TIE-2 receptor. Additionally, he has devised methods to block the growth or differentiation of these cells and to attenuate or prevent tumor growth in humans.
Career Highlights
Throughout his career, Maisonpierre has worked with prominent organizations, including Regeneron Pharmaceuticals, Inc. and the Max Planck Society for the Advancement of Science. His experience in these institutions has allowed him to collaborate with leading experts in the field.
Collaborations
Some of his notable coworkers include George D Yancopoulos and Samuel H Davis. Their collaborative efforts have contributed to advancements in the understanding and application of TIE-2 ligands.
Conclusion
Peter C Maisonpierre's innovative work in the field of biotechnology, particularly regarding TIE-2 ligands, showcases his significant contributions to medical science. His patents and collaborations highlight the potential for advancements in therapeutic applications.